Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

IDEXX Laboratories

STRATTEC SECURITY

Top Ranked Growth Stocks to Buy for December 14th

General Motors

Hologic

PerkinElmer

Top Ranked Growth Stocks to Buy for December 11th

Let's see if Owens & Minor (OMI) stock is a good choice for value-oriented investors right now from multiple angles.

Is Owens & Minor (OMI) a Worthy Pick for Value Investors?

QuidelOrtho Corp

Thermo Fisher Scientific

Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.

4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021

Hibbett Sports

Labcorp Holdings Inc

Top Ranked Growth Stocks to Buy for December 7th

California Water Service Group

Innoviva

Standard Motor Products

To combat market volatility, it is of utmost importance to create a portfolio of low-beta stocks.

Buy These 5 Low-Beta Stocks to Combat a Choppy Market

Ultra Clean

Top Ranked Growth Stocks to Buy for December 2nd

II-VI Incorporated

Top Ranked Growth Stocks to Buy for December 1st

Top Ranked Growth Stocks to Buy for November 27th

Fiverr

Nautilus

Overstock.com

Trade Desk

Here we pick five stocks -- OMI, NLS, TTD, OSTK, FVRR -- that have surged more than 200% this year and are safer investment choices than cryptocurrencies.

5 Top-Ranked Growth Stocks to Buy Instead of Bitcoin

Digital Turbine

Aviat Networks

Calix

Cambium Networks Corp

eXp World Holdings Inc

Sunopta

Tupperware

Vista Outdoor

While the gains are broad based, we have highlighted 10 stocks - APPS, OMI, EXPI, TUP, STKL, CALX, VSTO, CMBM, QDEL and AVNW - that have been on the forefront of the rally this year.

10 Stocks That Deserve Thanks in Pandemic-Ravaged 2020

RICHMOND, Va.--(BUSINESS WIRE)-- #fortune500--Owens & Minor to Present at the BofA Securities 2020 Leveraged Finance Conference

Owens & Minor to Present at the BofA Securities 2020 Leveraged Finance Conference

JELD-WEN Hld

Top Ranked Growth Stocks to Buy for November 20th

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Prepares for Flu Season with Increased Made-in-Americas Mask and N95 Respirator Capacity

Owens & Minor Prepares for Flu Season with Increased Made-in-Americas Mask and N95 Respirator Capacity

Owens & Minor (OMI) has been struggling lately, but the selling pressure may be coming to an end soon.

Owens & Minor (OMI) Sees Hammer Chart Pattern: Time to Buy?

Camping World Hlds

Kontoor Brands Inc

While comparing stocks, if other factors are similar, the one with higher earnings yield is considered undervalued.

Want to Bet on High Earnings Yield Stocks? Check Out These

Owens & Minor (OMI) reports solid revenue growth in its Global Products arm in the third quarter due to strength in PPE sales.

Owens & Minor's (OMI) Shares Fall Despite Q3 Earnings Beat

RICHMOND, Va.--(BUSINESS WIRE)-- #creditsuissehealthcareconference--Owens & Minor to Present at the 29th Annual Credit Suisse Healthcare Conference

Owens & Minor to Present at the 29th Annual Credit Suisse Healthcare Conference

DaVita

Brinker International

Group 1 Automotive

HomeStreet

Merit Medical Systems

Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

6 Stocks Near 52-Week Highs Poised to Appreciate Further

Owens & Minor, Inc. (OMI) CEO Ed Pesicka on Q3 2020 Results - Earnings Call Transcript

Owens & Minor (OMI) delivered earnings and revenue surprises of 15.71% and 5.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Beats Q3 Earnings and Revenue Estimates

Shares of Owens & Minor (NYSE:OMI) fell 0.61% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 305.00% year over year to $0.81, which beat the estimate of $0.67.

Owens & Minor: Q3 Earnings Insights

Owens & Minor's (OMI) PPE sales are likely to have maintained its momentum during Q3, thus driving the top line.

Owens & Minor (OMI) to Report Q3 Earnings: What's in Store?

AAR CORP.

Bed Bath & Beyond

Big Lots

Beazer Homes USA

Broker-favorite stocks like Big Lots (BIG), Bed Bath & Beyond (BBBY), AAR (AIR), Owens & Minor (OMI) and Beazer Homes (BZH) should be on an investor's watchlist in the quest for handsome returns.

5 Stocks Stealing the Limelight Post Recent Analyst Upgrade

RICHMOND, Va.--(BUSINESS WIRE)-- #earnings--Owens & Minor Will Report Third Quarter Financial Results on Monday, November 2, 2020

News for Owens & Minor Stock (OMI)